United States · FDA National Drug Code directory
Hiberix
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58160-818_9b08a2e7-7437-4c42-85a0-63bde50b4ea3
- Product NDC
- 58160-818
- Form
- KIT
- Composition / generic term
- Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
- Labeler
- GlaxoSmithKline Biologicals SA
- Marketing category
- BLA
- Marketing start / end (source format)
- 20151221
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (58160-818-11) * 10 VIAL in 1 CARTON (58160-816-05) / .5 mL in 1 VIAL (58160-816-01) * 10 VIAL in 1 PACKAGE (58160-817-05) / .85 mL in 1 VIAL (58160-817-01) · 58160-818-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →